Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Other Operating Expenses (2010 - 2026)

Exelixis (EXEL) posted quarterly Other Operating Expenses of $20.0 million for Q2 2026, up 4.07% year-over-year from $19.2 million in Q2 2025, and down 24.65% quarter-over-quarter from $26.5 million in Q1 2026.

Analysis

Exelixis (EXEL) Other Operating Expenses (2010 - 2026) Analysis & Trends

Exelixis' Other Operating Expenses history runs 16 years deep, the most recent figure standing at $20.0 million for Q2 2026.

  • In Q2 2026, Other Operating Expenses rose 4.07% year-over-year to $20.0 million; the TTM figure through Apr 2026 stood at $84.5 million (down 32.83% YoY), while the FY2026 annual figure was $83.7 million, down 34.53% from the prior year.
  • Other Operating Expenses for Q2 2026 stood at $20.0 million, down from $26.5 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $69.0 million in Q3 2024, with the low at $13.2 million in Q2 2022.
  • The 5-year median for Other Operating Expenses is $18.8 million (2023), against an average of $21.3 million.
  • The sharpest annual moves came in 2022 and 2024: Other Operating Expenses tumbled 91.16% in 2022, then jumped 267.53% in 2024.
  • Exelixis' Other Operating Expenses stood at $15.9 million in 2022, then jumped by 36.64% to $21.8 million in 2023, then surged by 217.2% to $69.0 million in 2024, then tumbled by 73.08% to $18.6 million in 2025, then climbed by 7.42% to $20.0 million in 2026.
  • Business Quant data shows EXEL's Other Operating Expenses at $20.0 million in Q2 2026, $26.5 million in Q1 2026, and $18.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 20.66 Mn
Apr 3, 2026 19.95 Mn
Jan 2, 2026 26.48 Mn
Oct 3, 2025 18.57 Mn
Jul 4, 2025 19.47 Mn
Apr 4, 2025 19.17 Mn
Jan 3, 2025 19.93 Mn
Sep 27, 2024 69.00 Mn
Jun 28, 2024 17.67 Mn
Mar 29, 2024 21.26 Mn
Dec 29, 2023 21.75 Mn
Sep 29, 2023 18.77 Mn
Jun 30, 2023 17.71 Mn
Mar 31, 2023 14.32 Mn
Dec 30, 2022 15.92 Mn
Sep 30, 2022 15.31 Mn
Jul 1, 2022 13.48 Mn
Apr 1, 2022 13.20 Mn
Dec 31, 2021 180.19 Mn
Oct 1, 2021 11.87 Mn